南方医科大学南方医院子宫内膜异位症推荐专家

简介:

南方医院，作为南方医科大学第一附属医院，是一所集医疗、教学、科研和预防保健为一体的综合性三级甲等医院。医院在子宫内膜异位症（endometriosis）等妇科疾病的治疗上具有显著的专业优势。医院设有52个专业学科，其中内科学（消化系病）是国家重点学科，消化内科是国家级重点专科。医院在消化病诊治、肾病的综合治疗等方面拥有明显的技术特色与优势。医院还设有专门的子宫内膜异位症（endometriosis）治疗团队，运用先进技术和设备，为患者提供全面的诊断和治疗服务。医院在子宫内膜异位症（endometriosis）领域的精湛医术和优质服务，赢得了患者的广泛赞誉。子宫内膜异位症（endometriosis）是指有活性的内膜细胞种植在子宫内膜以外的位置而形成的一种女性常见妇科疾病。内膜细胞本该生长在子宫腔内,但由于子宫腔通过输卵管与盆腔相通,因此使得内膜细胞可经由输卵管进入盆腔异位生长。，子宫内膜种植,免疫防御功能缺陷,遗传与体质的因素,内分泌功能失调，盆腔，子宫内膜异位症的治疗方案,因病情的轻重,患者的年龄和生育情况而有所不同。如病情较重,或表现为重的痛经,或盆腔检查发现有肯定的内膜异位结节,就必须采取药物或手术治疗，卵巢恶性肿瘤、盆腔炎性肿块和子宫腺肌病，尽量少吃含有雌激素的食物,如大豆、洋葱、黑米、小麦等，B型超声检查,腹腔镜检查,实验室检查，。

庞战军主任医师

三级甲等南方医科大学南方医院

好评率：接诊量：平均响应：

(1)宫颈癌、子宫内膜癌等妇科恶性肿瘤的腹腔镜微创手术治疗，以手术时间短、出血极少、创伤小、术后恢复快、患者生存率高和生存时间长为特点，尤其对于中晚期病例，采用辅助治疗与腹腔镜手术相结合的个体化综合治疗方案，达到理想治疗效果；(2)熟练运用腹腔镜、宫腔镜等微创手术、开腹手术、阴式手术等各类手术技巧，尤其擅长腹腔镜及宫腔镜微创手术治疗妇科疾病，根据患者病情选择并优化手术方式，为患者提供创伤小、效果好、低复发、性价比高的手术治疗方案；(3)妇科良、恶性肿瘤的诊治，尤其对宫颈癌、子宫内膜癌、卵巢癌等妇科恶性肿瘤的预防及综合治疗有丰富经验，对疑难及复杂病例的诊治有独到见解；(4)子宫脱垂、阴道壁膨出、月经失调、阴道异常流血、盆腔包块、不孕等妇科疑难、复杂疾病的诊断与治疗；(5)子宫内膜异位症的手术及药物治疗。

接诊医生：

2024-09-10 05:21:16

科普文章

子宫内膜异位症的类型与卵巢癌风险

以下内容来源于pubmed。

Endometriosis Typology and Ovarian Cancer Risk

Abstract

Importance: Endometriosis has been associated with an increased risk of ovarian cancer; however, the associations between endometriosis subtypes and ovarian cancer histotypes have not been well-described.

Objective: To evaluate the associations of endometriosis subtypes with incidence of ovarian cancer, both overall and by histotype.

Design, setting, and participants: Population-based cohort study using data from the Utah Population Database. The cohort was assembled by matching 78 893 women with endometriosis in a 1:5 ratio to women without endometriosis.

Exposures: Endometriosis cases were identified via electronic health records and categorized as superficial endometriosis, ovarian endometriomas, deep infiltrating endometriosis, or other.

Main outcomes and measures: Estimated adjusted hazard ratios (aHRs), adjusted risk differences (aRDs) per 10 000 women, and 95% CIs for overall ovarian cancer, type I ovarian cancer, and type II ovarian cancer comparing women with each type of endometriosis with women without endometriosis. Models accounted for sociodemographic factors, reproductive history, and past gynecologic operations.

Results: In this Utah-based cohort, the mean (SD) age at first endometriosis diagnosis was 36 (10) years. There were 597 women with ovarian cancer. Ovarian cancer risk was higher among women with endometriosis compared with women without endometriosis (aHR, 4.20 [95% CI, 3.59-4.91]; aRD, 9.90 [95% CI, 7.22-12.57]), and risk of type I ovarian cancer was especially high (aHR, 7.48 [95% CI, 5.80-9.65]; aRD, 7.53 [95% CI, 5.46-9.61]). Ovarian cancer risk was highest in women with deep infiltrating endometriosis and/or ovarian endometriomas for all ovarian cancers (aHR, 9.66 [95% CI, 7.77-12.00]; aRD, 26.71 [95% CI, 20.01-33.41]), type I ovarian cancer (aHR, 18.96 [95% CI, 13.78-26.08]; aRD, 19.57 [95% CI, 13.80-25.35]), and type II ovarian cancer (aHR, 3.72 [95% CI, 2.31-5.98]; aRD, 2.42 [95% CI, -0.01 to 4.85]).

Conclusions and relevance: Ovarian cancer risk was markedly increased among women with ovarian endometriomas and/or deep infiltrating endometriosis. This population may benefit from counseling regarding ovarian cancer risk and prevention and could be an important population for targeted screening and prevention studies.